EUCTR2004-001853-27-IT进行中（未招募）不适用
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients with Refractory / Relapsed Acute Lymphoblastic Leukaemia
BIOENVISIO0 个研究点开始时间: 2005年11月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients with Refractory / Relapsed Acute Lymphoblastic Leukaemia - BIOV-111Relapsed or refractory acute lymphoblastic leukaemia (ALL) in childrenMedDRA version: 8.0Level: LoweClassification code 10050281EUCTR2004-001853-27-ATBioenvision Limited100
进行中（未招募）
不适用
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute LeukemiasMedDRA version: 18.0Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864Acute Lymphoblastic LeukemiaEUCTR2015-001174-18-Outside-EU/EEAGenzyme Corporation15
进行中（未招募）
1 期
A study with a combination of two anticancer drugs as a salvage therapy for patients, affected by acute leukaemia aiming at lymphocites, adult not respondent to previous therapies or with a relapsing leukaemia.Acute Lymphoblastic Leukemia (ALL)MedDRA version: 14.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-019742-12-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
进行中（未招募）
1 期
A Randomized Phase II Study of Clofarabine / Intermediate-Dose Cytarabine (CLARA)versus High-Dose Cytarabine (HDAC) as Consolidation in Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML). - CLARAMedDRA version: 9.1Level: LLTClassification code 10000886Term: Acute myeloid leukemiaAcute Myeloid LeukemiaEUCTR2008-000668-18-FRHospices Civils de Lyon
进行中（未招募）
不适用
An open label phase II trial of Clofarabine and Temsirolimus in olderpatients with relapsed or refractory Acute Myeloid Leukemia (AML) - GIMEMA Protocol AML1107MedDRA version: 9.1Level: LLTClassification code 10000886Term: Acute myeloid leukemiaRelapsed or refractory Acute Myeloid Leukemia (AML)EUCTR2007-005374-31-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL`ADULTO